SCHEMBL1390232

SCHEMBL1390232

COc1ccc(C(=O)C=Cc2ccc(Br)cc2F)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.53
MAOA P21397 3/20 0.53
GPR183 P32249 5/20 0.46
KCNH2 Q12809 1/20 0.46
TNFRSF1A P19438 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MITF O75030 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
PAX8 Q06710 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NNMT P40261 1/20 0.44
DPP4 P27487 1/20 0.43
ALOX5 P09917 1/20 0.43
CTSL P07711 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390372 0.87 MAOB (0.54) MAOBMAOATNFRSF1ALMNASMN1; SMN2
SCHEMBL1390301 0.87 MAOB (0.55) MAOBMAOATNFRSF1AALDH1A1LMNA
SCHEMBL1390730 0.86 MAOB (0.65) MAOBMAOAALDH1A1LMNAMAPT
SCHEMBL1390298 0.86 MAOB (0.65) MAOBMAOAALDH1A1LMNAMAPT
SCHEMBL1390340 0.83 MAOB (0.66) MAOBMAOAMEN1KMT2AALDH1A1
SCHEMBL1390185 0.80 GPR183 (0.66) MAOBMAOAGPR183KCNH2MEN1
SCHEMBL18397357 0.79 MAOA (0.53) MAOBMAOATNFRSF1AMEN1KMT2A
SCHEMBL1390666 0.79 MAOB (0.58) MAOBMAOAKMT2AALDH1A1LMNA
SCHEMBL18397355 0.79 MAOA (0.53) MAOBMAOATNFRSF1AMEN1KMT2A
SCHEMBL13464612 0.77 CYP1B1 (0.52) MAOBMAOAMEN1KMT2AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 MAOB 1814/4885MAOA 2715/4885GPR183 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.